Isabel Chien

Safe Exploration in Dose Finding Clinical Trials with Heterogeneous Participants

In drug development, early phase dose-finding clinical trials are carried out to identify an optimal dose to administer to patients in larger confirmatory clinical trials. Standard trial procedures do not optimize for participant benefit and do not consider participant heterogeneity, despite consequ…